CD86 and metastatic malignant neoplasm in the lymph nodes: On the other hand, lymph node metastasis (p < 0.001), tumor multiplicity (p = 0.002) and CD86+/CD206+ TAMs model (p = 0.005) were selected to build the RFS nomogram (Fig. 6B).